Biotech's Chinese connection

Hodgson, G

doi:10.1126/science.255.5052.1635

Title: Biotech's Chinese connection

Full Record
Other Related Research

Abstract

Hong Kong last month opened the Hong Kong Institute of Biotechnology (HKIB), a nonprofit R and D center. By combining Chinese expertise in medicinal compounds and cell culturing with Western technical and marketing skills, the institute hopes to develop products that could be licensed to Hong Kong or Western films. The institute is also developing experimental cell lines and making genetically engineered versions of promising compounds, taking advantage of the cell-culturing and cloning skills that are highly developed on the mainland. The Shanghai contingent is already involved in one of the institute's projects, an effort to transfer human genes into mouse fibroblasts to create cell lines for research on the molecular mechanisms of learning and memory. Other Chinese researchers are taking part in HKIB's joint venture with Syntex, which was signed last April. The mainland researchers extract candidate medicinal compounds from plants and microorganisms. In Hong Kong, the compounds are tested for their effects on neurotransmitter receptors, while Syntex scientists in Palo Alto study how the same compounds affect enzyme activity and whole cells.

Authors:: Hodgson, G

Publication Date:: Fri Mar 27 00:00:00 EST 1992

OSTI Identifier:: 5176504

Resource Type:: Journal Article

Journal Name:: Science (Washington, D.C.); (United States)

Additional Journal Information:: Journal Volume: 255:5052; Journal ID: ISSN 0036-8075

Country of Publication:: United States

Language:: English

Subject:: 59 BASIC BIOLOGICAL SCIENCES; 29 ENERGY PLANNING, POLICY AND ECONOMY; BIOTECHNOLOGY; RESEARCH PROGRAMS; CHINA; CELL CULTURES; CLONING; GENETIC ENGINEERING; INTERNATIONAL COOPERATION; USA; ASIA; COOPERATION; DEVELOPED COUNTRIES; NORTH AMERICA; 550200* - Biochemistry; 290500 - Energy Planning & Policy- Research, Development, Demonstration, & Commercialization

Citation Formats


                    Hodgson, G. Biotech's Chinese connection.  United States: N. p., 1992. 
        Web.  doi:10.1126/science.255.5052.1635.

Copy to clipboard


                    Hodgson, G. Biotech's Chinese connection.  United States.  https://doi.org/10.1126/science.255.5052.1635

Copy to clipboard


                    Hodgson, G. 1992.  
        "Biotech's Chinese connection".  United States.  https://doi.org/10.1126/science.255.5052.1635.

Copy to clipboard


                    
@article{osti_5176504,

  title        = {Biotech's Chinese connection},

  author       = {Hodgson, G},

  abstractNote = {Hong Kong last month opened the Hong Kong Institute of Biotechnology (HKIB), a nonprofit R and D center. By combining Chinese expertise in medicinal compounds and cell culturing with Western technical and marketing skills, the institute hopes to develop products that could be licensed to Hong Kong or Western films. The institute is also developing experimental cell lines and making genetically engineered versions of promising compounds, taking advantage of the cell-culturing and cloning skills that are highly developed on the mainland. The Shanghai contingent is already involved in one of the institute's projects, an effort to transfer human genes into mouse fibroblasts to create cell lines for research on the molecular mechanisms of learning and memory. Other Chinese researchers are taking part in HKIB's joint venture with Syntex, which was signed last April. The mainland researchers extract candidate medicinal compounds from plants and microorganisms. In Hong Kong, the compounds are tested for their effects on neurotransmitter receptors, while Syntex scientists in Palo Alto study how the same compounds affect enzyme activity and whole cells.},

  doi          = {10.1126/science.255.5052.1635},

  url          = {https://www.osti.gov/biblio/5176504},
  journal      = {Science (Washington, D.C.); (United States)},

  issn         = {0036-8075},

  number       = ,

  volume       = 255:5052,

  place        = {United States},

  year         = {Fri Mar 27 00:00:00 EST 1992},

  month        = {Fri Mar 27 00:00:00 EST 1992}

}

Copy to clipboard

Journal Article:

https://doi.org/10.1126/science.255.5052.1635

Other availability

Find in Google Scholar

Search WorldCat to find libraries that may hold this journal

Save / Share:

Export Metadata

Save to My Library

Similar records in OSTI.GOV collections:

Thai group set to invest in Chinese petchem complex

Journal Article Alperowicz, N - Chemical Week; (United States)

A $5-billion refinery and petrochemical complex is planned by Thailand's Charoen Pokphand (Bangkok) at the seaport of Nimpoh, near Shanghai. The company has discussed the project with the central government of China, and state oil and petrochemicals company Sinopec (Beijing) is due to complete a feasibility study within the next two months. Charoen's plastics processing subsidiary, Kuo Shen (Hong Kong), is expected to hold 70% in the venture, Sinopec 20%, and the Chinese government the remaining 10%. Western companies have been invited to participate. Solvay (Brussels), a 49% partner with Charoen Pokphand in the Vinythai polyvinyl chloride (PVC) joint venturemore »« less
Neste plans three projects

Journal Article

Neste Chemicals (Helsinki) is discussing three joint ventures with local authorities in China, says Mikko Haapavaara, v.p./Asia. The projects should help the Finnish producer to increase sales in Asia by a considerable amount by 2000, he says. The plan involves production of polyethylene (PE), unsaturated polyester resins and PE compounding-all core operations. Sites have not been selected, but Shanghai is the favored location for the PE operations. The company is also looking at a site in the south, near Hong Kong, and at locations near Beijing. The PE plant would need to be near an ethylene unit, says Haapavaara. Themore »« less
Osteosarcoma of the maxilla in Hong Kong Chinese postirradiation for nasopharyngeal carcinoma. A report of four cases

Journal Article Dickens, P; Wei, W; Sham, J - Cancer (Philadelphia); (USA)

Postirradiation osteosarcoma of the maxilla was seen in four Hong Kong Chinese patients treated for nasopharyngeal carcinoma. These cases represent four of 42 (9%) cases of osteosarcoma at all sites in this institution during the period 1979 to 1989, when more than 1000 patients were treated with radiotherapy for nasopharyngeal carcinoma. The latent periods varied from 8 to 11 years from completion of radiotherapy treatment to development of osteosarcoma. The radiation dosage varied from 6000 to 6280 cGy in three of the patients. These cases fit the criteria for diagnosis of postirradiation sarcomas. Maxillary osteosarcomas after irradiation for nasopharyngeal carcinomamore »« less
https://doi.org/10.1002/1097-0142(19901101)66:9<1924::AID-CNCR2820660912>3.0.CO;2-9
Towards SEA for the developing nations of Asia

Journal Article Briffett, Clive; Obbard, Jeffrey; Mackee, Jamie - Environmental Impact Assessment Review

In the developing and transitional countries of Asia, environmental impact assessment (EIA) has been widely practiced as a planning tool that identifies the potential impacts associated with developments and determines their level of significance and the need for mitigating measures. Not withstanding its extensive use in many Asian countries, certain limitations are now being increasingly recognised with regard to achieving sustainable development within the planning process. It is also noted that the natural environment in Asia has continued to be severely degraded despite the adoption of EIA. This research project was undertaken at the National University of Singapore to reviewmore »« less
https://doi.org/10.1016/S0195-9255(02)00100-2
Titanium steam turbine blading

Conference Jaffee, R

After a long research and development period, beginning with the commercial availability of titanium in early 1950's, the steam turbine manufacturers and users have been developing titanium alloy blading for the long last row and steam transition row applications. Commercial introduction of titanium blading into low pressure steam turbines is just beginning in many countries over the world. A workshop was organized by the Electric Power Research institute and held in Palo Alto, California on November 9 and 10, 1988, to provide a record of the status of the development and to facilitate and accelerate the introduction of the titaniummore »« less

Similar Records